Detalles de la búsqueda
1.
Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis.
BMC Gastroenterol
; 24(1): 54, 2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291388
2.
Performance of two-dimensional shear wave elastography and transient elastography compared to liver biopsy for staging of liver fibrosis.
Eur J Clin Invest
; 53(7): e13980, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880934
3.
Protein Tyrosine Phosphatase Nonreceptor Type 2 Expression Does Not Correlate with Viral Load or Response to Direct-Acting Antiviral Therapy in Hepatitis C Virus Infections-Infected Patients.
Digestion
; 102(3): 453-461, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32074607
4.
Multimodal assessment of non-alcoholic fatty liver disease with transmission-reflection optoacoustic ultrasound.
Theranostics
; 13(12): 4217-4228, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37554280
5.
Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard.
Abdom Radiol (NY)
; 47(11): 3746-3757, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36038643
6.
Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease Patients.
Inflamm Intest Dis
; 6(1): 38-47, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33850838
7.
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohort.
Therap Adv Gastroenterol
; 13: 1756284820959252, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33281934
Resultados
1 -
7
de 7
1
Próxima >
>>